Current
Projects:
1.
An Automated Diagnostic Workflow for the Diagnosis of Pulmonary Embolism in the Presence of CTPA and Clinical Evidence
Our goal in this project is to develop an integrated computer aided decision support (CAD) system which, when introduced into the Physician's workflow as a "second reader" improves the diagnosis of acute PE with the following benefits: more accurate diagnosis, resulting in fewer complications from unnecessary anticoagulation therapy, and reduced costs and radiation exposure, from the elimination of unnecessary follow-up imaging studies.
Initial Funding:
IUPUI RSFG
2.
A Machine Learning Approach to Label-free Detection of Bacterial Pathogens using Laser Light Scattering
Technologies for rapid detection and classification of bacterial pathogens are crucial for securing the food supply. A light-scattering sensor recently developed for real-time detection and identification of colonies of multiple pathogens has shown great promise for distinguishing bacteria cultures at the genus and species level for Listeria, Staphylococcus, Salmonella, Vibrio, and Escherichia. Unlike traditional testing methods, this new technology does not require a labeling reagent or biochemical processing.
The classification approach currently used with this technology relies on supervised learning. For an accurate detection and classification of bacterial pathogens, the training library used to train the classifier should consist of samples of all possible forms of the pathogens. Construction of such a training library is impractical if not impossible due to the high mutation rate that characterizes some of the infectious agents.
In this project we propose to advance this sensor technology to allow for the detection of new classes/subclasses of bacteria, which do not exist in the training library. Learning with a nonexhaustive training library is an ill-defined problem. We design a two stage classification scheme to alleviate this problem. The first stage, i.e. detection, identifies whether the bacteria sample belongs to one of the subclasses in the training library or a yet unseen and thus unrepresented subclass. If the former is true, the sample is fed to the second stage, i.e. classification, where it is classified to one of the existing subclasses. If the latter is true, an alert is raised and the sample is saved for follow-up analysis.
Benefit for Public Health: Successful implementation of this project will allow for a label-free detection and identification of food pathogens and their mutated subclasses not yet seen earlier. This will reduce the number of food related outbreaks and will help secure our food supply.
Funding pending
3.
Predictive Mathematical Models of Intraductal Breast
Lesions
In the diagnosis of
early-stage breast cancer, some of the intraductal
lesions usually pose diagnostic difficulties, the
most frequently encountered of which is whether a
lesion represents epithelial hyperplasia or
carcinoma in situ. The main difficulty in this
differential diagnosis is due to an intermediate
category of intraductal proliferations between usual
epithelial hyperplasia(UDH) and Ductal Carcinoma in
situ (DCIS), called Atypical Ductal
Hyperplasia(ADH). ADH is most commonly considered as
a proliferative lesion that meets some but not all
criteria for low-grade, non-comedo type DCIS
(LG-DCIS). Even though neither UDH nor ADH are
precursors to carcinoma in situ or invasive
carcinoma, women with ADH, is prone to four to five
times increased risk of invasive breast carcinoma
compared to those in the general population.
The criteria used to define ADH
in histopathology is far from being perfect and the
interobserver variability in the classification of
all the “borderline” intraductal lesions, i.e. UDH
vs ADH and ADH vs LG-DCIS, remains extremely
significant. In a study that presents the results of
a systematic review of published studies involving
39,560 adult patients who were evaluated for breast
symptoms, it is found that the initial diagnosis of
ADH made by core biopsy, changed in 42% of the
patients as a result of excisional biopsy. Most
changes were to DCIS or invasive cancer, although
approximately 20% changed to more benign diagnoses.
The diagnosis of borderline intraductal lesions
requires extracting and analyzing a large number of
quantitative features at multiple resolutions, which
we believe is a task that can be more reliably and
accurately performed with assistance from predictive
mathematical systems. In this project, we propose to
develop a predictive system which, when introduced
into the pathologists’ workflow improves the
diagnosis of borderline intraductal lesions, thereby
provide the following health benefits: more accurate
diagnosis of early stage breast cancer, resulting in
fewer complications, less discomfort for the patient
and reduced cost from the elimination of unnecessary
resections. We will develop two predictive systems,
one for each of H&E and caPCNAab-stained breast
tissue samples and then conduct a reader study
involving at least three pathologists to clinically
validate each system in the diagnostic workflow as a
computer-based image analysis tool for providing
“second opinion” to the pathologists.
Funding pending
|